Multiple hematopoietic defects and delayed globin switching in Ikaros null mice

RA Lopez, S Schoetz, K DeAngelis… - Proceedings of the …, 2002 - National Acad Sciences
RA Lopez, S Schoetz, K DeAngelis, D O'Neill, A Bank
Proceedings of the National Academy of Sciences, 2002National Acad Sciences
We have previously reported the structure of a chromatin remodeling complex (PYR
complex) with Ikaros as its DNA binding subunit that is specifically present in adult murine
and human hematopoietic cells. We now show that homozygous Ikaros “knockout”(null)
mice lack the PYR complex, demonstrating the requirement for Ikaros in the formation of the
complex on DNA. Heterozygous Ikaros null mice have about half as much PYR complex,
indicating a dosage effect for both Ikaros and PYR complex. We also show that Ikaros null …
We have previously reported the structure of a chromatin remodeling complex (PYR complex) with Ikaros as its DNA binding subunit that is specifically present in adult murine and human hematopoietic cells. We now show that homozygous Ikaros “knockout” (null) mice lack the PYR complex, demonstrating the requirement for Ikaros in the formation of the complex on DNA. Heterozygous Ikaros null mice have about half as much PYR complex, indicating a dosage effect for both Ikaros and PYR complex. We also show that Ikaros null mice have multiple hematopoietic cell defects including anemia and megakaryocytic abnormalities, in addition to previously reported lymphoid and stem cell defects. The null mice also have a delay in murine embryonic to adult β-globin switching and a delay in human γ to β switching, consistent with a previously suggested role for PYR complex in this process. Lastly, cDNA array analyses indicate that several hematopoietic cell-specific genes in all blood lineages are either up- or down-regulated in 14-day embryos from Ikaros null as compared with wild-type mice. These results indicate that Ikaros and PYR complex function together in vivo at many adult hematopoietic cell-specific genes and at intergenic sites, affecting their expression and leading to pleiotropic hematopoietic defects.
National Acad Sciences